These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection. Gerretsen HE; Capone S; Vitelli A; Reyes LS; Thompson A; Jones C; Green CA; Pollard AJ; Sande CJ Vaccine; 2018 Nov; 36(46):6988-6994. PubMed ID: 30318168 [TBL] [Abstract][Full Text] [Related]
10. Pharmacist-driven respiratory syncytial virus prophylaxis stewardship service in a neonatal intensive care unit. Rostas SE; McPherson C Am J Health Syst Pharm; 2016 Dec; 73(24):2089-2094. PubMed ID: 27919877 [TBL] [Abstract][Full Text] [Related]
11. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Wong TM; Petrovsky N; Bissel SJ; Wiley CA; Ross TM Hum Vaccin Immunother; 2016 Aug; 12(8):2096-2105. PubMed ID: 27215855 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. Malkin E; Yogev R; Abughali N; Sliman J; Wang CK; Zuo F; Yang CF; Eickhoff M; Esser MT; Tang RS; Dubovsky F PLoS One; 2013; 8(10):e77104. PubMed ID: 24204744 [TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus: prospects for new and emerging therapeutics. Jorquera PA; Tripp RA Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data. Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. Walsh EE; Pérez Marc G; Zareba AM; Falsey AR; Jiang Q; Patton M; Polack FP; Llapur C; Doreski PA; Ilangovan K; Rämet M; Fukushima Y; Hussen N; Bont LJ; Cardona J; DeHaan E; Castillo Villa G; Ingilizova M; Eiras D; Mikati T; Shah RN; Schneider K; Cooper D; Koury K; Lino MM; Anderson AS; Jansen KU; Swanson KA; Gurtman A; Gruber WC; Schmoele-Thoma B; N Engl J Med; 2023 Apr; 388(16):1465-1477. PubMed ID: 37018468 [TBL] [Abstract][Full Text] [Related]
16. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. Rostad CA; Stobart CC; Gilbert BE; Pickles RJ; Hotard AL; Meng J; Blanco JCG; Moin SM; Graham BS; Piedra PA; Moore ML J Virol; 2016 Aug; 90(16):7508-7518. PubMed ID: 27279612 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults. Falsey AR; Williams K; Gymnopoulou E; Bart S; Ervin J; Bastian AR; Menten J; De Paepe E; Vandenberghe S; Chan EKH; Sadoff J; Douoguih M; Callendret B; Comeaux CA; Heijnen E; N Engl J Med; 2023 Feb; 388(7):609-620. PubMed ID: 36791161 [TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity. Maier C; Fuchs J; Irrgang P; Wißing MH; Beyerlein J; Tenbusch M; Lapuente D Front Immunol; 2022; 13():920256. PubMed ID: 36003372 [TBL] [Abstract][Full Text] [Related]
19. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. Madhi SA; Polack FP; Piedra PA; Munoz FM; Trenholme AA; Simões EAF; Swamy GK; Agrawal S; Ahmed K; August A; Baqui AH; Calvert A; Chen J; Cho I; Cotton MF; Cutland CL; Englund JA; Fix A; Gonik B; Hammitt L; Heath PT; de Jesus JN; Jones CE; Khalil A; Kimberlin DW; Libster R; Llapur CJ; Lucero M; Pérez Marc G; Marshall HS; Masenya MS; Martinón-Torres F; Meece JK; Nolan TM; Osman A; Perrett KP; Plested JS; Richmond PC; Snape MD; Shakib JH; Shinde V; Stoney T; Thomas DN; Tita AT; Varner MW; Vatish M; Vrbicky K; Wen J; Zaman K; Zar HJ; Glenn GM; Fries LF; N Engl J Med; 2020 Jul; 383(5):426-439. PubMed ID: 32726529 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study. Leroux-Roels G; De Boever F; Maes C; Nguyen TL; Baker S; Gonzalez Lopez A Vaccine; 2019 May; 37(20):2694-2703. PubMed ID: 30987852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]